Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism

Overview of attention for article published in Blood, July 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

patent: 8 patents

facebook: 1 Facebook page

Readers on

mendeley: 75 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Treatments administering chimeric IgG Fc receptor comprising an extracellular domain of…

Grant US-12590138-B2

United States of America

31 Mar 2026

Chimeric Receptors with Binding Capacity for Antibodies

Application WO-2025109493-A1

World Intellectual Property Organisation (WIPO)

30 May 2025

Bispecific T cell engager and uses thereof

Grant US-12269863-B2

United States of America

08 Apr 2025

NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors

Grant US-12188005-B2

United States of America

07 Jan 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.